South Africa Establishment Licence Application Document Checklist: GLF-MD-06A v5 Requirements

1. Key takeaways

A South African Establishment Licence application is submitted on the GLF-MD-06A series of forms (current version v5, September 2025). The core dossier comprises: company registration documents, the CV and letter of appointment of the Authorised Representative (AR), a list of all medical devices concerned, including nomenclature system codes, a statement on the status of the quality management system, a description of premises and storage or handling capability, and proof of payment. SAHPRA handles incomplete applications by returning them without processing, rather than reviewing while deficiencies are corrected. In addition, every page of the application form must be signed by the AR at the bottom, and printed forms corrected with white-out will be rejected.

Two features of this regime deserve emphasis. First, because an incomplete application never enters the processing queue, the cost of a single return is not just the time needed to fix the deficiency but the entire place in the queue. Second, the product list is the anchor of the application: changes that do not affect licensed device categories can be handled by written notification free of charge, while adding a device category requires a full amendment with payment of fees.

2. Legal basis

The table below lists the official sources relied upon, with the specific provisions governing application content and formal requirements.

3. Expert insights

Insight 1: Return without processing is the biggest procedural difference between South Africa and most other markets. In many jurisdictions the regulator first accepts an application and then issues deficiency notices; in South Africa an incomplete application does not enter the processing flow at all. This means that a single return costs not the time needed to supply the missing document, but the entire position in the queue. Companies should therefore run a complete internal formal review before submission, covering signatures, certified copies, version consistency and payment references, rather than hoping to fix problems after the file is on the regulator’s desk.

Insight 2: The product list is the core of the application form and the baseline for every later change. The application must list all medical devices that the entity manufactures, distributes or wholesales. The official position is clear: where a change to the product list does not affect the device categories already licensed, it can be handled by written notification free of charge; but adding a device category requires a full amendment and payment of fees. The granularity chosen when compiling the list directly determines the future cost of changes — organising the list by device category is far easier to maintain than listing individual SKUs, because routine catalogue expansions then fall on the free notification route.

Insight 3: The quality management system statement has two layers. The first layer is the QMS statement made at application time: Regulation 5(1)(c)(iii) requires acceptable written proof of quality management system certification for medical devices and IVDs. The second layer is the ISO 13485 certificate, which becomes mandatory step by step under the SAHPRA five-phase roadmap. What is submitted at application time is the statement plus other acceptable written proof; the ISO 13485 certificate itself becomes the operative requirement at renewal and in later phases. Planning both layers in parallel avoids a gap between the two regimes.

Insight 4: Formal requirements cause more rejections than substantive requirements. The official requirements include: the application form signed by the AR at the bottom of every page; the AR section and declaration fully signed; no corrections with white-out; all certificate copies certified; and both a printed and an electronic version submitted. Companies with filing experience on the Chinese mainland have no direct equivalent for these requirements, and they are the most frequently overlooked category of return reasons. A checklist that treats each formal element as a discrete verification item before dispatch is the cheapest insurance available.

Insight 5: The payment proof must be submitted separately with a traceable reference. Payment must carry the applicant name, telephone number or application number as a reference; the authorities recommend that one transaction corresponds to one item only, and where a single transaction covers multiple items a breakdown must be attached. Submitting the payment proof separately from the application is likewise a South African particularity. These rules exist so that finance staff can match funds to files without ambiguity; an unmatched payment sits in a suspense position while the application clock does not run.

4. Practical recommendations

The following actions operationalise the requirements above.

1. Run one complete formal self-check before submission: signatures, no white-out corrections, certified copies, and version consistency between the printed and electronic sets.
2. Organise the product list by device category: this lowers the frequency and cost of future amendments.
3. Prepare the QMS material in two layers: the application statement plus the ISO 13485 certification pathway in parallel.
4. Submit payment as a separate document with a complete reference: one transaction per item where possible, to prevent funds from going unmatched.
5. Prepare the printed and electronic versions simultaneously: submit in exactly the form the official requirements prescribe.
6. Retain a copy of the application and the acknowledgement of receipt: both are needed for later amendments, renewal and inspections.

5. Verification checklist

Confirm every item below before dispatching the dossier.

• □ Company registration documents are complete and within their validity period
• □ AR CV and the company letter of appointment have been prepared
• □ The application form has been signed by the AR at the bottom of every page, and the declaration section fully signed
• □ The printed form carries no white-out corrections
• □ All attached certificate copies have been certified
• □ The product list covers all devices with category and nomenclature system codes indicated
• □ The QMS statement has been submitted and the ISO 13485 pathway planned
• □ Proof of payment has been submitted separately with complete reference details

Regulatory information verified as of 29 October 2026. The regulations, guidance and effective dates described in this article are limited to the official sources listed in the legal basis section above, as published on that date. Where official documents are subsequently updated, the latest published version prevails.

• South Africa local resources: GRZAN assists manufacturers from the Chinese mainland and overseas with SAHPRA medical device Establishment Licence (MDEL) applications and product registration preparation, including Authorised Representative (AR) scheme design, ISO 13485 certification pathway planning and CAB selection, GMDN coding and classification determination, technical documentation preparation, and the establishment of vigilance and adverse event reporting mechanisms.
• Service capabilities: product attribute determination and risk classification (Class A/B/C/D), establishment licence application and renewal, reliance pathway justification, technical documentation and Essential Principles conformity argumentation, labelling and instructions-for-use localisation (English), and post-market vigilance and annual compliance information submission support.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.